(0)

DIA会员及用户请点击登录

登录

忘记用户 ID？ or 忘记密码？

Not a Member?

创建账户并加入。

Hilton Washington DC/Rockville Hotel & Executive Meeting Ctr.

2017 年 09 月 13 日 1:00 下午 - 2017 年 09 月 13 日 4:30 下午

1750 Rockville Pike, , Rockville, MD 20852 , USA

Course 2: Preparing Documents for Disclosure and Public Sharing

概览

Short Course* Registration: 7:30AM-4:30PM

*Short Courses are not included in the conference registration and require a separate fee.
Recent clinical trial transparency regulations have been developed to provide greater access to clinical trial information. As a result, the pharmaceutical industry is changing its approach to responsibly, sharing the results of clinical trials and addressing what information needs to be released, when, and how in order to comply with these recent regulations. This short course will focus on the European Medicine Agency’s (EMA) Publication Policy 0070 and the US Department of Health and Human Services (HHS) Final Rule for Section 801 of the US Food and Drug Administration Amendments Act (FDAAA) of 2007. We will discuss how these recent US and EU regulations related to data disclosure are being implemented and will also focus on the application of preparing such documents for disclosure. This short course is appropriate for medical writers who will be preparing documents for disclosure.
Return to Clinical Trial Disclosure and Data Transparency Conference

学习目标

At the conclusion of this short course, participants should be able to:

  • Define what is in scope, the timing, and requirements of the EMA Policy 0070 and HHS Final Rule
  • Discuss how regulatory documents can be prepared for disclosure
  • Apply best practices in developing layperson summaries
  • Discuss the impact of clinical trial disclosure regulations and initiatives on publication deliverables

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表，了解DIA的观点和事件。